Case Study: DiscGenics automates and scales quality processes with ETQ Reliance

DiscGenics® Automates their Quality Processes

DiscGenics is a pre-revenue biotechnology company developing an off‑the‑shelf spinal cell therapy (IDCT) to treat degenerative disc disease. As the team grew, their manual, paper‑based quality processes became time‑consuming, error‑prone and hard to scale; they needed an affordable, user‑friendly Quality Management System that would support preclinical and clinical work, minimize headcount for document control, and be accessible to staff without GMP experience.

DiscGenics implemented ETQ Reliance as a turn‑key QMS, centralizing document control, automating reviews and approvals, and linking deviations to CAPA, test validation and quality records. The change reduced paperwork, sped data capture and inspections with electronic forms and in‑system guidance, improved productivity and quality culture, and positioned the company to expand quality controls as it moves toward commercialization.

DiscGenics

Randy Domingo

Head of Quality